Jäckle S, Rinninger F, Lorenzen T, Greten H, Windler E
Medizinische Kernklinik und Poliklinik, Universitäts-Krankenhaus Eppendorf, Hamburg, Germany.
Hepatology. 1993 Mar;17(3):455-65. doi: 10.1002/hep.1840170316.
The trafficking of apolipoprotein E-deficient high-density lipoprotein particles and of their component cholesteryl esters in rat hepatocytes was studied. Human high-density lipoprotein 3, labeled with two nondegradable, intracellularly trapped tracers in their apolipoprotein A-I and their cholesteryl esters, were injected into rats, and five subcellular hepatocytic fractions were isolated at various time intervals. In control experiments with homologous lipoproteins, doubly labeled rat high-density lipoproteins depleted of apolipoprotein E were used. In endosomes and lysosomes the two labels were recovered at near unity, indicating that high-density lipoproteins are endocytosed as particles, transported to early and late endosomes and finally subjected to lysosomal degradation. No significant amounts of label were found in receptor-recycling endosomes. In contrast to label of those of low-density lipoproteins, label of component protein and cholesteryl esters of high-density lipoproteins from isolated endosomes floated at different densities in gradient ultracentrifugation, indicating early disintegration of high-density lipoprotein particles. In contrast to the endocytic organelles, in the whole liver, label of high-density lipoprotein-associated cholesteryl esters exceeded the label of high-density lipoprotein-associated apolipoprotein A-I twofold to threefold. This finding is compatible with selective uptake of high-density lipoprotein cholesteryl esters in addition to uptake of high-density lipoprotein particles. The excess cholesteryl esters accumulated in a nonendosomal fraction, whose major proteins differed from the integral proteins of endosomes. These data suggest two distinct intracellular routes of hepatocytic high-density lipoprotein trafficking in vivo. High-density lipoproteins free of apolipoprotein E are internalized intact by hepatocytes, are predominantly transported to early and late endosomes and are finally subjected to lysosomal degradation. High-density lipoprotein particles do not undergo retroendocytosis in hepatocytes. In addition, high-density lipoprotein-associated cholesteryl esters can be taken up by hepatocytes selectively. They, however, accumulate in a nonendosomal, nonlysosomal compartment.
研究了载脂蛋白E缺乏的高密度脂蛋白颗粒及其胆固醇酯成分在大鼠肝细胞中的转运情况。将用人载脂蛋白A-I及其胆固醇酯中两种不可降解的细胞内捕获示踪剂标记的人高密度脂蛋白3注入大鼠体内,并在不同时间间隔分离出五个亚细胞肝细胞组分。在使用同源脂蛋白的对照实验中,使用了去除载脂蛋白E的双标记大鼠高密度脂蛋白。在内体和溶酶体中,两种示踪剂的回收率接近100%,表明高密度脂蛋白作为颗粒被内吞,转运至早期和晚期内体,最终进行溶酶体降解。在受体循环内体中未发现大量示踪剂。与低密度脂蛋白的示踪剂不同,从分离的内体中提取的高密度脂蛋白的组成蛋白和胆固醇酯的示踪剂在梯度超速离心中以不同密度漂浮,表明高密度脂蛋白颗粒早期解体。与内吞细胞器不同,在整个肝脏中,高密度脂蛋白相关胆固醇酯的示踪剂比高密度脂蛋白相关载脂蛋白A-I的示踪剂高出两到三倍。这一发现与除了摄取高密度脂蛋白颗粒外,选择性摄取高密度脂蛋白胆固醇酯是一致的。过量的胆固醇酯积聚在一个非内体组分中,其主要蛋白质与内体的整合蛋白不同。这些数据表明,在体内肝细胞高密度脂蛋白转运存在两条不同的细胞内途径。不含载脂蛋白E的高密度脂蛋白被肝细胞完整内化,主要转运至早期和晚期内体,最终进行溶酶体降解。高密度脂蛋白颗粒在肝细胞中不发生逆向内吞作用。此外,高密度脂蛋白相关胆固醇酯可被肝细胞选择性摄取。然而,它们积聚在一个非内体、非溶酶体区室中。